Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma

Author:

Singh Shailendra R12,Sullo Nikol13,Matteis Maria3,Spaziano Giuseppe3,McDonald John1,Saunders Ruth2,Woodman Lucy2,Urbanek Konrad3,De Angelis Antonella3,De Palma Raffaele4,Berair Rachid2,Pancholi Mitesh2,Mistry Vijay2,Rossi Francesco3,Guerrini Remo5,Calò Girolamo6,D'Agostino Bruno3,Brightling Christopher E2,Lambert David G1

Affiliation:

1. Department of Cardiovascular Sciences, University of Leicester, Division of Anaesthesia, Critical Care and Pain Management; Leicester Royal Infirmary; Leicester LE2 7LX UK

2. Institute for Lung Health, Department of Infection, Immunity and Inflammation and Health Sciences; University of Leicester; Leicester UK

3. Department of Experimental Medicine, Section of Pharmacology L Donatelli,; Second University of Naples; Naples Italy

4. Department of Clinical and Experimental Medicine, Division of Immunology; Second University of Naples; Naples Italy

5. Department of Chemical and Pharmaceutical Sciences; University of Ferrara; Ferrara Italy

6. Department of Medical Sciences, Section of Pharmacology; University of Ferrara; Ferrara Italy

Publisher

Wiley

Subject

Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3